Study Links Diabetes Drugs To Heart Disease
The New England Journal of Medicine released information on a study in 2013, showing that when comparing patients who had been given a placebo with patients who were given a drug containing the active ingredient saxagliptin, those who took saxagliptin had a nearly 30% higher chance of developing heart failure. Both Kombiglyze and Onglyza contain saxagliptin.
After learning about the study’s results, the FDA convened a review board to look over data they requested from AstraZeneca and Bristol-Myers Squibb. Of the fifteen people reviewing the information, the majority determined that the drug could remain on the market, however, a black box warning needed to be issued, informing doctors and patients that the drug may cause congestive heart failure.
Share this Image On Your Site
Congestive Heart Failure & Complications
Medications, hospitalization, surgical procedures, physical therapy, and home care are all treatments that may be required by someone who has had a heart attack or is in heart failure. The cost of these treatments can be exorbitant, putting extreme financial strain a patient who already has enough stress to deal with.
Cost Of Medical Care
Did you know that on average, each time a patient is hospitalized it costs $9,700? Or that of all medical conditions, heart failure has the highest rate of rehospitalization within 30 days? This is in addition to the $100 – $1,600 patients spend monthly on their medications and doesn’t include the cost of surgery or other testing that might be performed. Bear in mind – this is simply the cost of care for heart disease – patients who developed heart disease because of saxagliptin are already battling Type 2 diabetes.
On top of all this, there are some common complications associated with heart failure, such as:
If the heart isn’t working properly, it can’t pump blood properly. The kidneys are especially sensitive to this and if nutrient rich blood doesn’t reach the kidneys, the patient may end up in renal failure.
Another common issue among patient with heart disease is fluid buildup. Unfortunately, in addition to putting pressure on the lungs and being uncomfortable in general, if not caught and treated, this fluid can also put pressure on the liver causing damage.
Poor blood flow and irregular heartbeats increase the risk of a patient developing a blood clot that could travel anywhere in the body.
If a patient develops any one of these complications, they could easily end up spending more time in the hospital and require additional expensive care.
Who Is At Risk?
Currently, Onglyza and Kombiglyze are two of the most popular medications prescribed to treat Type 2 diabetes on the market – and anyone who takes this drug could be at risk. In 2016 alone, Onglyza sales topped more than $192 million.
The Current Litigation
In the many lawsuits filed against AstraZeneca and Bristol-Myers Squibb, plaintiffs are claiming that the companies failed to properly warn physicians and their patients about the risks of developing heart failure if prescribed Onglyza or Kombiglyze.
These cases are still in the early stages but hundreds more are expected to be filed in the coming months.
How Do I Know If I’m Eligible To File A Lawsuit?
The best way to determine if you or a loved one are one of the thousands eligible to file an Onglyza or Kombiglyze lawsuit, contact us. We will review your case and determine all legal avenues available to you. Keep in mind that there are statutes of limitations associated with product liability cases, so the sooner you contact us the better.